Previous 10 | Next 10 |
UST Platform's Ultra-low Droplet Sizes and Test Verified Stability Portends Revolution in Major Markets SOUTH EASTON, MA / ACCESSWIRE / December 22, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressur...
Pressure BioSciences (OTCQB: PBIO ), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industri...
Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022 Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET SOUTH EASTON, MA / ACCESSWIRE / November 17, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "C...
During the semiannual review, Clovis Oncology (NASDAQ:CLVS), Maastercraft Boat (NASDAQ:MCFT), Asana (NYSE:ASAN), Five9 (NASDAQ:FIVN), Upstart (NASDAQ:UPST), Passage Bio (OTC:PBIO), American Vanguard (NYSE:AVD), Brightcove (NASDAQ:BCOV), 22nd Century (NASDAQ:XXII) and Duluth (NASDAQ:DLTH) ...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of its second U.S. patent ...
Pressure BioSciences (OTC:PBIO) announces the award of the second U.S. patent for the company's Ultra Shear Technology (UST) platform. The company's UST platform was created to revolutionize the processing of immiscible liquids into high quality, highly valuable, long-term stab...
Dynamically-Adaptive Compact Valve is Key Component in the Company's Highly Anticipated and Proprietary UST Platform; UST Expected to Help Deliver Strong Sales Growth and Profitability in 2022 SOUTH EASTON, MA / ACCESSWIRE / November 11, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, high pressure-based instruments, platform technologies and related consumables for the worldwide life sciences, agriculture, food and beverage, and other key industries, toda...
Titans and Emerging Leaders of Biopharma Struggling with Protein Misfolding and Aggregation Issues that Threaten Enormous Revenue Potentials Are Turning to PBI's Uniquely Enabling BaroFold Solution REMINDER: PBI to Participate in the Benzinga Virtual ALL ACCESS Investor Event ...
Pressure BioSciences (OTCQB: PBIO) (“PBI”) , a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and services to the worldwide life sciences and other key industries, today announced its participation in Benzinga's ALL ACCESS Inve...
News, Short Squeeze, Breakout and More Instantly...
Pressure BioSciences Inc Company Name:
PBIO Stock Symbol:
OTCMKTS Market:
Pressure BioSciences Inc Website:
Pressure BioSciences (OTCQB: PBIO) , a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemulsion products and services across global industries, today announced a partnership with Vita-Forte, the larg...
CANTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBIO” or the “Company”), a leading innovator in high-pressure nanotechnology and a pioneer in the development of novel, broadly-enabling, pressure-based instruments and nanoemul...
Pressure BioSciences (OTCQB: PBIO) , a pioneer in the development and distribution of broadly enabling pressure-based instruments, consumables and specialty process development and testing services across global industries, today announced that it will host a teleconference to update investors an...